MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS
Clinical trials for MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for anemia patients: drug may cut need for blood transfusions
Disease control OngoingThis study tests a drug called luspatercept in people with anemia caused by myelodysplastic syndromes (MDS) or beta-thalassemia who need regular blood transfusions. The goal is to see if the drug is safe and can reduce the number of transfusions needed. About 85 participants in I…
Matched conditions: MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug may cut transfusions for MDS patients
Disease control OngoingThis study tests a drug called luspatercept in 70 adults with a low-risk form of MDS that causes anemia. The goal is to see if the drug can reduce the need for red blood cell transfusions. Participants receive the drug and are monitored for safety and effectiveness over time.
Matched conditions: MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS
Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC